Carl Zeiss, Olympus enter licensing agreement for digital pathology patents

Carl Zeiss Microscopy (Jena, Germany) and Olympus America (Center Valley, PA) have entered into a nonexclusive worldwide licensing agreement that allows Carl Zeiss to access an extensive portfolio of patents held by Olympus in digital pathology and virtual microscopy. The patents included cover methods and equipment for creating, storing, and delivering virtual microscopy slides, enabling individuals to view and share high-resolution virtual microscopy images over the Internet.

"The handling of digital data has become a major driver of the development of modern microscopy,” says Dr. Bernhard Ohnesorge, Carl Zeiss Microscopy Board member and general manager, BioSciences Division. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”

“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” says Brad Burklow, executive director business development, Scientific Equipment Group, Olympus Corporation of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”

The companies are not making specific terms and conditions of the agreement public.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow Laser Focus World on your iPhone or Android

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Leica Biosystems set to acquire Aperio

Leica Biosystems has entered into a definitive agreement to acquire Aperio, a digital pathology solutions company.

ULTRAFAST LASERS/BIOCHEMICAL ANALYSIS: Optical frequency comb enables biochemical analysis in real time for bacterial disinfection method

Measurements made with an ultrafast-laser-generated optical frequency comb are helping to explain for the first time how a new sterilization technique inactivates bacteria without the use of liquid...

Average Joes challenge medical pros in telepathology game

Researchers in the Ozcan Research Group at UCLA have taken telepathology-which enables pathology in a remote location-into the video-gaming world.

Brian Wong, Ph.D., MD

Webcast to cover OCT utility in the eye, nose, and throat area

On Thursday, June 28, at 12 p.m. EST, join BioOptics World for a free, live, one-hour webcast on optical coherence tomography (OCT) in the eye, nose, and throat (ENT) area, which is promising for d...

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS